Journal article
Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome
Abstract
Acute coronary syndrome (ACS) is a medical emergency. Patients who survive the initial event remain at risk of recurrent cardiovascular events. In most cases, ACS is triggered by thrombosis after rupture of an atherosclerotic plaque. Key to thrombus formation at this site is the generation of thrombin, which not only converts fibrinogen to fibrin but also serves as a potent platelet agonist and induces platelet aggregation at the site of …
Authors
Weitz J
Journal
Thrombosis and Haemostasis, Vol. 112, No. 05, pp. 924–931
Publisher
Thieme
Publication Date
2014
DOI
10.1160/th14-03-0265
ISSN
0340-6245
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Acute Coronary SyndromeAnticoagulantsAntithrombinsCardiovascular DiseasesClinical Trials as TopicDrug SynergismDrug Therapy, CombinationFactor Xa InhibitorsFollow-Up StudiesHumansMulticenter Studies as TopicMyocardial InfarctionPlaque, AtheroscleroticPlatelet Aggregation InhibitorsRandomized Controlled Trials as TopicRecurrenceRupture, SpontaneousStrokeThrombin